Hanan A. Henidi

890 total citations · 1 hit paper
16 papers, 564 citations indexed

About

Hanan A. Henidi is a scholar working on Organic Chemistry, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Hanan A. Henidi has authored 16 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 3 papers in Pathology and Forensic Medicine and 3 papers in Oncology. Recurrent topics in Hanan A. Henidi's work include Quinazolinone synthesis and applications (5 papers), Synthesis and biological activity (4 papers) and Synthesis and Characterization of Heterocyclic Compounds (2 papers). Hanan A. Henidi is often cited by papers focused on Quinazolinone synthesis and applications (5 papers), Synthesis and biological activity (4 papers) and Synthesis and Characterization of Heterocyclic Compounds (2 papers). Hanan A. Henidi collaborates with scholars based in Saudi Arabia, Egypt and Italy. Hanan A. Henidi's co-authors include Ohoud Y. Alshehri, Awatif Rashed Z. Almotairy, Mohammed S. Aldughaim, Azeez Yusuf, Elshaymaa I. Elmongy, Nashwah G. M. Attallah, Najla Altwaijry, Fahad A. Al‐Abbasi, Ahmed M. Al‐Abd and Mohamed A. El‐Moselhy and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Hanan A. Henidi

14 papers receiving 550 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanoparticles as Drug Delivery Systems: A Review of the Implication of Nanoparticles’ Physicochemical Properties on Responses in Biological Systems

2023 443 citations Azeez Yusuf, Awatif Rashed Z. Almotairy et al. Polymers profile →

Peers

Countries citing papers authored by Hanan A. Henidi

Since Specialization

Citations

This map shows the geographic impact of Hanan A. Henidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanan A. Henidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanan A. Henidi more than expected).

Fields of papers citing papers by Hanan A. Henidi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanan A. Henidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanan A. Henidi. The network helps show where Hanan A. Henidi may publish in the future.

Co-authorship network of co-authors of Hanan A. Henidi

This figure shows the co-authorship network connecting the top 25 collaborators of Hanan A. Henidi. A scholar is included among the top collaborators of Hanan A. Henidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanan A. Henidi. Hanan A. Henidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	From Hue to Health: Exploring the Therapeutic Potential of Plant-Pigment-Enriched Extracts 2025 ·Microorganisms ·Azza S. El-Demerdash, (unknown), (unknown), Hanan A. Henidi, (unknown), Ghada E. Dawwam	0
2	Thymol Preserves Spermatogenesis and Androgen Production in Cisplatin-Induced Testicular Toxicity by Modulating Ferritinophagy, Oxidative Stress, and the Keap1/Nrf2/HO-1 Pathway 2025 ·Biomolecules ·Amira M. Badr, (unknown), (unknown), Hanan A. Henidi, Elshaymaa I. Elmongy, (unknown), Aliyah Almomen, Sahar Soliman	1
3	Cuproptosis Contributes to Cisplatin-Induced Nephrotoxicity: Insights into Thymol’s Potential Inhibitory and Protective Effects 2025 ·Pharmaceuticals ·(unknown), Amira M. Badr, Reem T. Atawia, Elshaymaa I. Elmongy, Hanan A. Henidi, (unknown), (unknown), (unknown), Nervana Bayoumy, Yasmen F. Mahran	0
4	Novel methotrexate long-acting system using ambroxol coating and hydroxypropyl methylcellulose encapsulation for preferential and enhanced lung cancer efficiency 2025 ·PLoS ONE ·Samaa Abdullah, Najla Altwaijry, (unknown), (unknown), (unknown), Hanan A. Henidi, Yahya F. Jamous	4
5	Crystal Engineering Approach to Forming Cocrystals of Enaminones: Structural Insights into Enhanced Solid-State Luminescence 2025 ·Crystal Growth & Design ·(unknown), Cheng Zou, (unknown), (unknown), Rabia Usman, (unknown), (unknown), (unknown), Hanan A. Henidi, May Bin‐Jumah, (unknown), Faiz‐Ur Rahman, Arshad Khan	1
6	Natural Inhibitors of Salmonella MDR Efflux Pumps AcrAB and AcrD: An Integrated In Silico, Molecular, and In Vitro Investigation 2024 ·International Journal of Molecular Sciences ·Azza S. El-Demerdash, (unknown), (unknown), Hanan A. Henidi, (unknown), Hadil Alahdal, Abdulrahman M. Saleh, (unknown)	6
7	Acceptor-Induced Cooperative Mixed-Stacking Supramolecular Co-Assembly with Enhanced Emissive Characteristics 2024 ·Crystal Growth & Design ·Cheng Zou, (unknown), (unknown), Rabia Usman, (unknown), Hanan A. Henidi, May Bin‐Jumah, (unknown), Faiz‐Ur Rahman, Arshad Khan	1
8	Cytotoxic Potential of Novel Quinoline Derivative: 11-(1,4-Bisaminopropylpiperazinyl)5-methyl-5H-indolo[2,3-b]quinoline against Different Cancer Cell Lines via Activation and Deactivation of the Expression of Some Proteins 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Elshaymaa I. Elmongy, Hanan A. Henidi, (unknown), Ibrahim El Tantawy El Sayed, (unknown), Mabrouk Attia Abd Eldaim	2
9	In Silico Screening and Anticancer-Apoptotic Evaluation of Newly Synthesized Thienopyrimidine/Sulfonamide Hybrids 2023 ·International Journal of Molecular Sciences ·Elshaymaa I. Elmongy, (unknown), Ohoud Y. Alshehri, (unknown), (unknown), Hanan A. Henidi	9
10	Nanoparticles as Drug Delivery Systems: A Review of the Implication of Nanoparticles’ Physicochemical Properties on Responses in Biological Systems breakdown → 2023 ·Polymers ·Azeez Yusuf, Awatif Rashed Z. Almotairy, Hanan A. Henidi, Ohoud Y. Alshehri, Mohammed S. Aldughaim	443
11	In Silico Evaluation of a Promising Key Intermediate Thieno [2,3-d] Pyrimidine Derivative with Expected JAK2 Kinase Inhibitory Activity 2022 ·SHILAP Revista de lepidopterología ·Elshaymaa I. Elmongy, Hanan A. Henidi	8
12	In-Silico Screening of Novel Synthesized Thienopyrimidines Targeting Fms Related Receptor Tyrosine Kinase-3 and Their In-Vitro Biological Evaluation 2022 ·Pharmaceuticals ·Elshaymaa I. Elmongy, Najla Altwaijry, Nashwah G. M. Attallah, (unknown), Hanan A. Henidi	22
13	Alternative Medicine Interventions for COVID-19 2021 ·Muhammad Zia‐Ul‐Haq, May Bin‐Jumah, (unknown), Hanan A. Henidi	17
14	Design and Synthesis of New Thiophene/Thieno[2,3-d]pyrimidines along with Their Cytotoxic Biological Evaluation as Tyrosine Kinase Inhibitors in Addition to Their Apoptotic and Autophagic Induction 2021 ·Molecules ·Elshaymaa I. Elmongy, Nashwah G. M. Attallah, Najla Altwaijry, (unknown), Hanan A. Henidi	16
15	Despite Blocking Doxorubicin-Induced Vascular Damage, Quercetin Ameliorates Its Antibreast Cancer Activity 2020 ·Oxidative Medicine and Cellular Longevity ·Hanan A. Henidi, Fahad A. Al‐Abbasi, Mohamed A. El‐Moselhy, Hany M. El‐Bassossy, Ahmed M. Al‐Abd	26
16	Design and synthesis of novel phenylaminopyrimidines with antiproliferative activity against colorectal cancer 2019 ·RSC Advances ·Hanan A. Henidi, Ahmed M. Al‐Abd, Fahad A. Al‐Abbasi, (unknown), Ibrahim M. El‐Deeb	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact